Old Web
English
Sign In
Acemap
>
authorDetail
>
Joachim Hoechel
Joachim Hoechel
Bayer
Medicine
Pharmacokinetics
Levonorgestrel
Ranibizumab
Macular degeneration
4
Papers
24
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Determining the Exposure Threshold for Levonorgestrel Efficacy Using an Integrated Model Based Meta-Analysis Approach
2021
Clinical Pharmacology & Therapeutics
Karthik Lingineni
Ayyappa Chaturvedula
Brian Cicali
Rodrigo Cristofoletti
Thomas Wendl
Joachim Hoechel
Joshua D. Brown
Valvanera Vozmediano
Stephan Schmidt
Show All
Source
Cite
Save
Citations (0)
Pharmacokinetics and Safety of the Selective Progesterone Receptor Modulator Vilaprisan in Chinese Healthy Postmenopausal Women
2020
Clinical pharmacology in drug development
Hongzhong Liu
Ji Jiang
Zhaozhao Chen
Yunhui Zhang
Jinyi Li
Joachim Hoechel
Beate Rohde
Torsten Zimmermann
Marcus‐Hillert Schultze‐Mosgau
Show All
Source
Cite
Save
Citations (3)
Quantitative assessment of levonorgestrel binding partner interplay and drug-drug interactions using physiologically based pharmacokinetic modeling.
2020
Brian Cicali
Karthik Lingineni
Rodrigo Cristofoletti
Thomas Wendl
Joachim Hoechel
Herbert Wiesinger
Ayyappa Chaturvedula
Valvanera Vozmediano
Stephan Schmidt
Show All
Source
Cite
Save
Citations (3)
The Developing Regorafenib Eye drops for neovascular Age‐related Macular degeneration (DREAM) study: an open‐label phase II trial
2019
British Journal of Clinical Pharmacology
Antonia M. Joussen
Sebastian Wolf
Peter K. Kaiser
David S. Boyer
Thomas Schmelter
R Sandbrink
Oliver Zeitz
Gesa Deeg
Annett Richter
Torsten Zimmermann
Joachim Hoechel
Ulf Buetehorn
Walter Schmitt
Brigitte Stemper
Michael K. Boettger
Show All
Source
Cite
Save
Citations (18)
1